98%
921
2 minutes
20
Masked uncontrolled hypertension (MUCH) in treated hypertensive patients is defined as controlled automated office blood pressure (BP; <135/85 mm Hg) in-clinic but uncontrolled out-of-clinic BP by ambulatory BP monitoring (awake [daytime] readings ≥135/85 mm Hg or 24-hour readings ≥130/80 mm Hg). To determine whether MUCH is attributable to antihypertensive medication nonadherence. One hundred eighty-four enrolled patients were confirmed to have controlled office BP; of these, 167 patients were with adequate 24-hour ambulatory BP recordings. Of 167 patients, 86 were controlled by in-clinic BP assessment but had uncontrolled ambulatory awake BP, indicative of MUCH. The remaining 81 had controlled in-clinic and ambulatory awake BP, consistent with true controlled hypertension. After exclusion of 9 patients with missing 24-hour urine collections, antihypertensive medication adherence was determined based on the detection of urinary drugs or drug metabolites by high-performance liquid chromatography-tandem mass spectrometry. Of the 81 patients with MUCH, 69 (85.2%) were fully adherent and 12 (14.8%) were partially adherent (fewer medications detected than prescribed). Of the 77 patients with true controlled hypertension, 69 (89.6%) were fully adherent with prescribed antihypertensive medications and 8 (10.4%) were partially adherent. None of the patients in either group were fully nonadherent. There was no statistically significant difference in complete or partial adherence between the MUCH and true controlled groups (P=0.403). Measurement of urinary drug and drug metabolite levels demonstrates a similarly high level of antihypertensive medication adherence in both MUCH and truly controlled hypertensive patients. These findings indicate that MUCH is not attributable to antihypertensive medication nonadherence.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6687528 | PMC |
http://dx.doi.org/10.1161/HYPERTENSIONAHA.119.13258 | DOI Listing |
J Glaucoma
September 2025
Department of Ophthalmology, University of Campinas, Campinas, São Paulo, Brazil.
Prcis: Gonioscopy-Assisted Transluminal Trabeculotomy achieved a higher success rate than Bent Ab interno Needle Goniotomy in pseudophakic primary open angle glaucoma eyes at 12-months.
Purpose: To evaluate and compare efficacy and safety of standalone Bent Ab interno Needle Goniotomy (BANG) and Gonioscopy-Assisted Transluminal Trabeculotomy (GATT) in pseudophakic primary open angle glaucoma (POAG) eyes.
Methods: Parallel, double-arm, 1:1 ratio, single masked, single surgeon, randomized clinical trial.
Clin Ophthalmol
August 2025
Regional Medical Affairs Department, Laboratorios Sophia, S.A. de C.V, Jalisco, Mexico.
Purpose: Maximal medical therapy involves using three or more classes of topical anti-glaucoma agents to achieve the target intraocular pressure (IOP). This study compared the effectiveness, tolerability, and safety of a fixed combination of timolol, dorzolamide, brimonidine, and latanoprost (TDB-L) versus a fixed combination of timolol, dorzolamide, and latanoprost (TD-L) for uncontrolled IOP in patients with primary open-angle glaucoma.
Methods: In this randomized, double-masked Phase IV trial, 47 eyes from 26 patients were assigned to TDB-Lor TD-L for 60 days, with follow-ups on days 14, 30, and 60.
Ophthalmol Sci
March 2025
NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK.
Objective: To report safety and early pharmacodynamic results from a first-in-human trial of intravitreal (IVT) anti-semaphorin 3A antibody in participants with diabetic macular ischemia (DMI).
Design: HORNBILL, a phase I/IIa study of BI 764524, comprised a nonrandomized, open-label, uncontrolled, single-rising-dose (SRD) and masked, randomized, sham-controlled, multiple-dose (MD) parts.
Participants: Adults with DMI and stable diabetic retinopathy (DR) treated with pan-retinal photocoagulation and without center-involving diabetic macular edema.
Nutr Metab Cardiovasc Dis
June 2025
Department of Cardiology, West China Hospital, Sichuan University, Chengdu, 610041, China. Electronic address:
Background And Aims: Metabolic status and obesity are considered to be related to the risk of hypertension. However, whether metabolic health and obesity status affect blood pressure (BP) control remains unknown. This study aimed to explore the prevalence of BP phenotypes in patients receiving single-pill combination (SPC) treatment and the associations of metabolic health and obesity status with BP phenotypes.
View Article and Find Full Text PDFJ Korean Med Sci
June 2025
Division of Cardiology, Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
Background: Identifying masked uncontrolled hypertension (MUCH) and white-coat uncontrolled hypertension (WUCH) without ambulatory blood pressure (ABP) monitoring is challenging. Recent literature advocates intensive blood pressure (BP) control, but standard guidelines still suggest a clinic BP threshold of ≥ 149/90 mmHg to diagnose hypertension. This study explored the impact of different clinic BP targets on the prevalence and predictors of MUCH and WUCH.
View Article and Find Full Text PDF